Abstract
Aim: To examine whether the center type and socioeconomic factors significantly impact 1-month mortality and overall survival (OS) of patients with diffuse large B-cell lymphoma (DLBCL). Methods: National Cancer Database (NCDB) was used to identify patients diagnosed with diffuse large B-cell lymphoma from 2006 to 2012 (postrituximab era). Results: Among 185,183 patients, 33% were treated at academic centers. The receipt of therapy at larger volume centers was associated with improved 1-month mortality. Academic centers had better OS than nonacademic centers in univariable analysis. Younger age, private insurance, lower Charlson comorbidity score and lower lymphoma stage were associated with improved 1-month mortality and OS. Conclusion: The receipt of therapy at larger volume centers and socioeconomic factors were associated with improved survival.
Original language | English (US) |
---|---|
Pages (from-to) | 2113-2124 |
Number of pages | 12 |
Journal | Future Oncology |
Volume | 15 |
Issue number | 18 |
DOIs | |
State | Published - Jun 2019 |
Keywords
- academic center
- cancer care
- center volume
- diffuse large B-cell lymphoma
- disparity
- mortality
- socioeconomic factors
- survival
ASJC Scopus subject areas
- Oncology
- Cancer Research